Your browser doesn't support javascript.
loading
Reply to: Comments on "(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer".
Rosas, Juan C; Aguado-Barrera, Miguel E; Azria, David; Briers, Erik; Elliott, Rebecca; Farcy-Jacquet, Marie-Pierre; Giraldo, Alexandra; Gutiérrez-Enríquez, Sara; Rancati, Tiziana; Rattay, Tim; Reyes, Victoria; Rosenstein, Barry; De Ruysscher, Dirk; Sperk, Elena; Stobart, Hilary; Talbot, Christopher; Vega, Ana; Taboada-Valladares, Begoña; Veldeman, Liv; Ward, Tim; Webb, Adam; West, Catharine; Chang-Claude, Jenny; Seibold, Petra.
Afiliação
  • Rosas JC; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Aguado-Barrera ME; Institute for Medical Information Processing, Biometry and Epidemiology, Ludwig-Maximilians University, Munich, Germany.
  • Azria D; Instituto de Investigación Sanitaria de Santiago de Compostela, Fundación Pública Galega de Medicina Xenómica (FPGMX), Santiago de Compostela, Spain.
  • Briers E; University of Montpellier, INSERM U1194 IRCM, Institut du Cancer Montpellier (ICM), Montpellier, France.
  • Elliott R; Patient advocate, Hasselt, Belgium.
  • Farcy-Jacquet MP; University of Manchester, Manchester, UK.
  • Giraldo A; Federation Universitaire d'Oncologie Radiothérapie d'Occitanie Méditerranée, Institut du Cancer Du Gard (ICG), CHU Carémeau, Nîmes, France.
  • Gutiérrez-Enríquez S; Radiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Rancati T; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Rattay T; Istituto Nazionale dei Tumori, Data Science Unit, Milan, Italy.
  • Reyes V; University of Leicester, Leicester, UK.
  • Rosenstein B; Radiation Oncology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • De Ruysscher D; Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Sperk E; Maastro Clinic, Maastricht, The Netherlands.
  • Stobart H; KU Leuven, Leuven, Belgium.
  • Talbot C; Universitätsmedizin Mannheim, Mannheim Cancer Center, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Vega A; Independent Cancer Patients' Voice, London, UK.
  • Taboada-Valladares B; University of Leicester, Leicester, UK.
  • Veldeman L; Instituto de Investigación Sanitaria de Santiago de Compostela, Fundación Pública Galega de Medicina Xenómica (FPGMX), Santiago de Compostela, Spain.
  • Ward T; Biomedical Network on Rare Diseases (CIBERER), Seville, Spain.
  • Webb A; Instituto de Investigación Sanitaria de Santiago de Compostela, Fundación Pública Galega de Medicina Xenómica (FPGMX), Santiago de Compostela, Spain.
  • West C; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
  • Chang-Claude J; Ghent University Hospital, Ghent, Belgium.
  • Seibold P; Ghent University, Ghent, Belgium.
Int J Cancer ; 154(4): 759-761, 2024 Feb 15.
Article em En | MEDLINE | ID: mdl-37908014
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article